Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, Ontario. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.
Wellbeing Digital Sciences Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Wellbeing Digital Sciences Inc 주요 수익원은 Association Fees이며, 최신 수익 발표에서 수익은 2,994,000입니다. 지역별로는 United States이 Wellbeing Digital Sciences Inc의 주요 시장이며, 수익은 5,838,000입니다.
Wellbeing Digital Sciences Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Wellbeing Digital Sciences Inc의 순손실은 $-31입니다.
Wellbeing Digital Sciences Inc에 부채가 있나요?
예, Wellbeing Digital Sciences Inc의 부채는 14입니다.
Wellbeing Digital Sciences Inc의 발행 주식은 몇 주인가요?
Wellbeing Digital Sciences Inc의 총 발행 주식은 119.03주입니다.